NASDAQ:ICUI - ICU Medical Stock Price, News & Analysis

$161.66
-4.75 (-2.85 %)
(As of 08/25/2019 04:00 PM ET)
Today's Range
$160.6750
Now: $161.66
$167.0250
50-Day Range
$162.22
MA: $224.04
$258.34
52-Week Range
$160.00
Now: $161.66
$312.45
Volume149,926 shs
Average Volume323,213 shs
Market Capitalization$3.34 billion
P/E Ratio20.97
Dividend YieldN/A
Beta0.81
ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency connectors; SwabCap disinfecting caps; Tego hemodialysis connectors; NovaCath and SuperCath peripheral intravenous (IV) catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:ICUI
CUSIP44930G10
Phone949-366-2183

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.40 billion
Cash Flow$11.4734 per share
Book Value$63.77 per share

Profitability

Net Income$28.79 million

Miscellaneous

Employees8,100
Market Cap$3.34 billion
Next Earnings Date11/14/2019 (Estimated)
OptionableOptionable

Receive ICUI News and Ratings via Email

Sign-up to receive the latest news and ratings for ICUI and its competitors with MarketBeat's FREE daily newsletter.


ICU Medical (NASDAQ:ICUI) Frequently Asked Questions

What is ICU Medical's stock symbol?

ICU Medical trades on the NASDAQ under the ticker symbol "ICUI."

How were ICU Medical's earnings last quarter?

ICU Medical, Incorporated (NASDAQ:ICUI) posted its earnings results on Wednesday, August, 7th. The medical instruments supplier reported $1.99 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $1.86 by $0.13. The medical instruments supplier had revenue of $312.30 million for the quarter, compared to analyst estimates of $315.47 million. ICU Medical had a return on equity of 12.41% and a net margin of 3.56%. ICU Medical's revenue was down 13.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.69 EPS. View ICU Medical's Earnings History.

When is ICU Medical's next earnings date?

ICU Medical is scheduled to release their next quarterly earnings announcement on Thursday, November 14th 2019. View Earnings Estimates for ICU Medical.

What guidance has ICU Medical issued on next quarter's earnings?

ICU Medical issued an update on its FY19 earnings guidance on Wednesday, August, 7th. The company provided earnings per share guidance of $7.55-8.15 for the period, compared to the Thomson Reuters consensus estimate of $9.30.

What price target have analysts set for ICUI?

1 analysts have issued 12-month price targets for ICU Medical's shares. Their predictions range from $300.00 to $300.00. On average, they expect ICU Medical's share price to reach $300.00 in the next twelve months. This suggests a possible upside of 85.6% from the stock's current price. View Analyst Price Targets for ICU Medical.

What is the consensus analysts' recommendation for ICU Medical?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ICU Medical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for ICU Medical.

Has ICU Medical been receiving favorable news coverage?

Headlines about ICUI stock have trended positive on Sunday, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. ICU Medical earned a news impact score of 2.5 on InfoTrie's scale. They also gave media stories about the medical instruments supplier a news buzz of 6.0 out of 10, indicating that recent press coverage is somewhat likely to have an effect on the stock's share price in the near future. View News Stories for ICU Medical.

Who are some of ICU Medical's key competitors?

What other stocks do shareholders of ICU Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ICU Medical investors own include Becton Dickinson and (BDX), CA (CA), BlackRock (BLK), Endologix (ELGX), Chipotle Mexican Grill (CMG), UnitedHealth Group (UNH), Alibaba Group (BABA), ABIOMED (ABMD), GW Pharmaceuticals PLC- (GWPH) and Aegean Marine Petroleum Network (ANW).

Who are ICU Medical's key executives?

ICU Medical's management team includes the folowing people:
  • Mr. Vivek Jain, Chairman & CEO (Age 47)
  • Mr. Scott E. Lamb, CFO & Treasurer (Age 56)
  • Mr. Christian B. Voigtlander, Chief Operating Officer (Age 51)
  • Ms. Virginia Ruth Sanzone, Corp. VP, Gen. Counsel & Sec. (Age 44)
  • Mr. Thomas D. McCall, Corp. VP of Marketing & Communications and GM of Critical Care (Age 61)

Who are ICU Medical's major shareholders?

ICU Medical's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Price T Rowe Associates Inc. MD (16.83%), Janus Henderson Group PLC (13.71%), Janus Henderson Group PLC (13.71%), Vanguard Group Inc. (8.52%), BlackRock Inc. (7.56%) and BlackRock Inc. (7.54%). Company insiders that own ICU Medical stock include Alison D Burcar, Christian B Voigtlander, Daniel Woolson, George A Lopez, Joseph R Saucedo, Kevin J Mcgrody, Pfizer Inc, Robert S Swinney, Scott E Lamb, Thomas D Mccall, Virginia Ruth Sanzone and Vivek Jain. View Institutional Ownership Trends for ICU Medical.

Which major investors are selling ICU Medical stock?

ICUI stock was sold by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, Putnam Investments LLC, Vanguard Group Inc., Los Angeles Capital Management & Equity Research Inc., Morgan Stanley, Russell Investments Group Ltd., GW&K Investment Management LLC and Public Employees Retirement System of Ohio. Company insiders that have sold ICU Medical company stock in the last year include Christian B Voigtlander, Kevin J Mcgrody, Pfizer Inc, Robert S Swinney, Scott E Lamb and Virginia Ruth Sanzone. View Insider Buying and Selling for ICU Medical.

Which major investors are buying ICU Medical stock?

ICUI stock was purchased by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, Findlay Park Partners LLP, Janus Henderson Group PLC, Janus Henderson Group PLC, Wells Fargo & Company MN, Invesco Ltd., Rice Hall James & Associates LLC and BlackRock Inc.. View Insider Buying and Selling for ICU Medical.

How do I buy shares of ICU Medical?

Shares of ICUI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ICU Medical's stock price today?

One share of ICUI stock can currently be purchased for approximately $161.66.

How big of a company is ICU Medical?

ICU Medical has a market capitalization of $3.34 billion and generates $1.40 billion in revenue each year. The medical instruments supplier earns $28.79 million in net income (profit) each year or $7.71 on an earnings per share basis. ICU Medical employs 8,100 workers across the globe.View Additional Information About ICU Medical.

What is ICU Medical's official website?

The official website for ICU Medical is http://www.icumed.com/.

How can I contact ICU Medical?

ICU Medical's mailing address is 951 CALLE AMANECER, SAN CLEMENTE CA, 92763. The medical instruments supplier can be reached via phone at 949-366-2183 or via email at [email protected]


MarketBeat Community Rating for ICU Medical (NASDAQ ICUI)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  302 (Vote Outperform)
Underperform Votes:  307 (Vote Underperform)
Total Votes:  609
MarketBeat's community ratings are surveys of what our community members think about ICU Medical and other stocks. Vote "Outperform" if you believe ICUI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ICUI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/25/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel